| CAS No. | 518048-05-0 |
|---|---|
| MDL No. | N/A |
| MF | C20H21FN6O5 |
| MW | 444.40 |
| InChI Key | CZFFBEXEKNGXKS-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Raltegravir is a pyrimidone (pyrimidin-4(3H)-one) with substituents at positions 2, 3, 5, and 6: 2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl, methyl, hydroxy, and N-[(4-fluorophenyl)methyl]aminoacyl, respectively. It is an antiretroviral drug used in the treatment of HIV infection. It functions as a HIV-1 integrase inhibitor and is classified as an antiviral drug, 1,2,4-oxadiazole, dicarboxylic acid amide, monofluorobenzene, hydroxypyrimidine, and secondary carboxamide.
| CAS No. | 518048-05-0 |
|---|---|
| Product Name | Raltegravir |
| Heavy Atom Count | 32 | Rotatable Bond Count | 6 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 9 | HBD | 3 |
| TPSA | 152.240 Ų | Charge | 0 |
| Exact Mass | 444.15575 | Complexity | 1232.27 |
| pKa | 1.573 | XLogP | 0.912 |
